ZenBio, Inc. Awarded $1.38 Million Phase II SBIR Grant for Skeletal Muscle Program
Published: Sep 30, 2008
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--ZenBio, Inc. announced that it has been awarded a Phase II SBIR grant to commercialize their primary human skeletal myocyte and adipocyte co-culture system. The $1.38 million award from the National Institutes of Health will fund the continued optimization and commercial development of this unique tool for type 2 diabetes and obesity research.